The global cytomegalovirus assay market registered at a CAGR of over 6.1% during the forecast period 2019–2025. Cytomegalovirus belongs to herpes viridae family and it is comprised of DNA virus. This infection is shown to be asymptomatic in some cases and may causes mild influenza like indications; and later stays dormant all through life, which may relapse. This infection results in asymptomatic contaminations in immunocompromised people and can be transmitted to the embryo while pregnancy and leads to congenital CMV. Hence, an effective CMV assay is required to treat CMV infection which is fueling the market growth.

Some of the key players in the market are Abbott, Qiagen, Abcam plc, Danaher Corporation, Becton Dickson, Biomerieux, Eiken Chemicals, Elitech Group, Fujirebio , Affymetrix, Inc., F. Hoffmann-La Roche Ltd., Olympus Corporation, Siemens Healthcare, Thermo Fisher Scientific, Inc., NeumoDx and DiaSorin Molecular.

Increasing prevalence of CMV globally is likely to boost the global Cytomegalovirus Assay Market

According to the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), it is reported that CMV infects all age group, and also infects one-third of children in the US. Infection is generally asymptomatic in most of the immunocompromised patients, transplant and transfusion recipients, as well as new-born neonates. This factor is expected to propel the market growth of CMV assay.

The global cytomegalovirus assay market is bifurcated based on the assay type, application, end-user, and regional analysis. Based on the assay type, the market is divided into serology, cell culture, antigenemia, polymerase chain reaction amplification, immunohistochemistry, nucleic acid sequence-based amplification (NASBA), hybrid capture assay. Based on the application, the market is divided into retinitis, pneumonia, gastrointestinal ulcers, encephalitis, and others. Based on end user it is classified into diagnostic laboratories, pathology labs, life sciences and research labs and others.

The Asia Pacific Region Expected to Witness fastest Growth in the Global Cytomegalovirus Assay Market

Based on geographical analysis, the global cytomegalovirus assay market is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The growth of the cytomegalovirus Assay market across Asia Pacific is due to the surge in the patient population suffering from CMV assay. Furthermore, the increasing healthcare expenditure and emerging new companies focused on conducting clinical trials on CMV and new treatment method to cure these infections will propel the growth of the industry in the region.

 Global Cytomegalovirus Assay Market - By Application (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, Others), By End user (Diagnostic Laboratories, Pathology Labs, Life Sciences and Research Labs, Others),  By Assay type (Immunohistochemistry, Serology, Cell culture, Antigenemia, Polymerase Chain Reaction Amplification, Nucleic acid sequence-based amplification (NASBA), Hybrid capture assay), and By Region - Global Industry Perspective, Comprehensive Analysis, And Forecast, 2019 – 2025.” 

Request For Sample of this Report: click here

The global cytomegalovirus assay market is segmented as follows:

By Assay Type:

  • Serology
  • Cell culture
  • Antigenemia
  • Polymerase Chain Reaction Amplification
  • Immunohistochemistry
  • Nucleic acid sequence-based amplification (NASBA)
  • Hybrid capture assay

 

By Application:

  • Retinitis
  • Pneumonia
  • Gastrointestinal Ulcers
  • Encephalitis
  • Others

By End user:

  • Diagnostic Laboratories
  • Pathology Labs
  • Life Sciences and Research Labs
  • Others

By region:

  • North America

The U.S.

Canada

  • Europe

France

The UK

Spain

Germany

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Southeast Asia

Rest of Asia Pacific

  • Latin America

Brazil

Mexico

Rest of Latin America

  • Middle East & Africa

GCC

South Africa

Rest of Middle East & Africa

About Us:

FAST.MR is a global market research and business-consulting organization that aims to provide a deep market insight to our clients, which helps them in better decision making in the dynamic environment. We have a team of highly qualified personnel that studies the market in-depth to provide our clients with better strategies to stand out in the market.

Our report covers the current market status, opportunities available in the market, growth plans, and emerging trends in order to cater to the evolving needs of the customers. We help businesses around the globe with operational improvements, technologies, emerging market trends that in-depth boost the company’s growth in the future. The reports prepared by us are customized according to the client’s needs. We inculcate high morale and ethics while preparing our report which helps in building long-term relationships with our clients.

Contact Us:
Fast.MR
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: [email protected]
Website: www.fastmr.com

Request For Customization



Request Customization

Check Discount



Request Discount